These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6273617

  • 1. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N, Ohsawa N, Kusaba R, Inou T, Takada M.
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [Abstract] [Full Text] [Related]

  • 2. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
    Akiyama N, Ohsawa N, Samaru Y, Kusaba R.
    Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
    [Abstract] [Full Text] [Related]

  • 3. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M, Matej H, Duś D, Myc A.
    Arch Immunol Ther Exp (Warsz); 1983 Apr; 31(6):879-85. PubMed ID: 6331341
    [Abstract] [Full Text] [Related]

  • 4. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T, Hirano T, Sakaguchi N, Teranishi T, Tsuyuguchi I, Nagao N, Naito N, Yoshimura K, Okubo Y, Tohda H, Oikawa A.
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [Abstract] [Full Text] [Related]

  • 5. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
    Tanaka Y, Sugamura K, Hinuma Y, Sato H, Okochi K.
    J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y, Sugamura K, Hinuma Y.
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 11. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H, Touraine JL.
    Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
    [Abstract] [Full Text] [Related]

  • 12. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G, Stimson WH.
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S, Takasaki T, Okuno K, Yasutomi M, Kurane I.
    Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
    [Abstract] [Full Text] [Related]

  • 16. Relative lack of Epstein Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults.
    Gervais F, Wills A, Leyritz M, Lebrun A, Joncas JH.
    J Immunol; 1981 Mar; 126(3):897-900. PubMed ID: 6257786
    [Abstract] [Full Text] [Related]

  • 17. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Mar; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 18. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S.
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [Abstract] [Full Text] [Related]

  • 19. Some Epstein-Barr virus-transformed B lymphoblastoid cell lines have an altered structure around the mixed lymphocyte culture-inducing domain on DR molecules.
    Nagayoshi T, Morito F, Kaneoka H, Yamaguchi M.
    Fukuoka Igaku Zasshi; 1986 May; 77(5):287-92. PubMed ID: 3017826
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.